Metraipolis › archive › dc_78b44bb26cae
2CT2-2-EtO — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/2CT2-2-EtO
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-06T12:13:31.619Z
- SHA-256 of the archived text
cebcbd5a4da7015ff08e9e23f1370992c4b91e599b0a132d7fe9a93cf4b93518- Stable URL of this page
https://metraipolis.com/documento/dc_78b44bb26cae
How to cite
2CT2-2-EtO — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/2CT2-2-EtO (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_78b44bb26cae (Metraipolis archive dc_78b44bb26cae, sha256 cebcbd5a4da7015ff08e9e23f1370992c4b91e599b0a132d7fe9a93cf4b93518)
BibTeX
@misc{dc78b44bb26cae,
title = {2CT2-2-EtO — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/2CT2-2-EtO},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_78b44bb26cae; sha256 cebcbd5a4da7015ff08e9e23f1370992c4b91e599b0a132d7fe9a93cf4b93518},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/2CT2-2-EtO. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
2CT2-2-EtO, also known as 2-ethoxy-4-ethylthio-5-methoxyphenethylamine, is a psychedelic drug of the phenethylamine, 2C, and TWEETIO families related to 2C-T-2. It is the derivative of 2C-T-2 in which the methoxy group at the 2 position has been replaced with an ethoxy group. According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CT2-2-EtO has a "completely effective" dose of 50 mg orally, a typical dose of 10 mg intranasally but with considerable variation between individuals, and a duration of 5 to 6 hours or of 9 hours. Its onset is said to be "very quick". The effects of 2CT2-2-EtO have been reported to include blurred vision, intense closed-eye visuals, generation of a pleasant and contemplative mood, restless sleep, and weird dreams. Due to the large ~5-fold increase in potency when taken intranasally instead of orally, 2CT2-2-EtO may undergo substantial first-pass metabolism with oral administration. The chemical synthesis of 2CT2-2-EtO has been described. 2CT2-2-EtO was first described in the literature by Shulgin in PiHKAL in 1991. It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin. The drug is a controlled substance in Canada under phenethylamine blanket-ban language. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «2CT2-2-EtO» — https://en.wikipedia.org/wiki/2CT2-2-EtO Wikidata Q138545903: «pharmaceutical compound» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q138545903 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/2CT2-2-EtO?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1348519004, consultata il 2026-11-06T12:10:59.968Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 78158d6bd0513d8078da48eea3bf16be4aa5f5ce7fd158bcd2389f2e6283a6ff